A carregar...
Secondary mutations as mediators of resistance to targeted therapy in leukemia
The advent of small molecule-based targeted therapy has improved the treatment of both acute and chronic leukemias. Resistance to small molecule inhibitors has emerged as a common theme. The most frequent mode of acquired resistance is the acquisition of point mutations in the kinase domain. FLT3 in...
Na minha lista:
Publicado no: | Blood |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society of Hematology
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4440880/ https://ncbi.nlm.nih.gov/pubmed/25795921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-10-605808 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|